April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
A Novel Bruch’s Membrane Substrate from Human Donor Lens Anterior Capsule
Author Affiliations & Notes
  • Nikolaos Kopsachilis
    Ophthalmology, University of Erlangen - Nuremberg, Erlangen, Germany
  • Theofilos Tourtas
    Ophthalmology, University of Erlangen - Nuremberg, Erlangen, Germany
  • Konstantinos Tsaousis
    2nd Department of Ophthalmology, Aristotles University of Thessaloniki, Thessaloniki, Greece
  • Friedrich E. Kruse
    Ophthalmology, University of Erlangen - Nuremberg, Erlangen, Germany
  • Ulrich Welge-Luessen
    Ophthalmology, University of Erlangen - Nuremberg, Erlangen, Germany
  • Footnotes
    Commercial Relationships  Nikolaos Kopsachilis, None; Theofilos Tourtas, None; Konstantinos Tsaousis, None; Friedrich E. Kruse, None; Ulrich Welge-Luessen, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 4020. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Nikolaos Kopsachilis, Theofilos Tourtas, Konstantinos Tsaousis, Friedrich E. Kruse, Ulrich Welge-Luessen; A Novel Bruch’s Membrane Substrate from Human Donor Lens Anterior Capsule. Invest. Ophthalmol. Vis. Sci. 2011;52(14):4020.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To study the potential use of human donor anterior lens capsule (AC) as a Bruch’s membrane substrate for human retinal pigment epithelium cell transplantation.

Methods: : AC’s were recovered from the lenses of 30 cornea donors 24 to 72 hours post mortem. Human retinal pigment epithelium cells (RPE) were recovered from the remaining retinal fragments of 15 eye donors. The capsules were treated with Trypsin/EDTA solution and stored in distilled water for 12 hours to eliminate the crystalline epithelium. After initial processing, primary cultured RPE’s were added on the AC’s and allowed to attach in culture at 37°C. Samples were sorted into 3 groups. Group 1 consisted of 10 samples in which the RPE cells were allowed to grow on corresponding capsules. Group 2 consisted of RPE cells that were allowed to grow on a collagen membrane. Group 3 consisted of 10 samples in which human RPE cells were allowed to grow on polystyrene culture plates (Control). All specimens were incubated for 2 weeks at 37°C and 5% CO2. Cell density, morphology, and adherence of the cell-capsule complex were evaluated at 1, 4, 7 and 14 days with a phase-contrast microscope, a scanning electron microscope and by histology. Cell viability was quantified by a microscopic live-dead assay. Expression of zonula occludens-1 (ZO-1), Na+/K+-adenosine triphosphatase (Na+/K+-ATPase), tissue transglutaminase (tTgase) and vimentin were investigated by immunohistochemistry.

Results: : A mean diameter of 10,05 ± 0,13 mm of anterior capsule was obtained as a substrate for cell culture. The rate of cell growth in all three groups was comparable. Cell viability was 96% or superior in all groups and multiple cellular interconnections developed between growing cells. Immunohistochemical analysis demonstrated strongly positive staining for ZO-1, tTgase, vimentin and Na+/K+-ATPase. Electron microscopy confirmed the adherence and monolayer growth of the RPE cells on the non epithelial side of the lens capsule.

Conclusions: : Phenotypical properties of the cell-capsule complex imply that the RPE-capsule complex is capable of maintaining intact barrier and ionic pump functions in vitro. Human donor anterior lens capsule might therefore be a potential scaffold for the ex vivo expansion of human RPE cells and could be used as a potential Bruch’s membrane substrate in retinal surgery.

Keywords: age-related macular degeneration • retina • retinal pigment epithelium 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×